BIO RESPONSE INC
10KSB, 1998-05-06
BLANK CHECKS
Previous: VALUE LINE CASH FUND INC, 497J, 1998-05-06
Next: JMB INCOME PROPERTIES LTD VII, 10-K405/A, 1998-05-06




                     Bio-Response, Inc.
              SECURITIES AND EXCHANGE COMMISSION
                     WASHINGTON, D.C. 20549
                                
                           FORM 10-KSB
                                
[X]ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
   EXCHANGE ACT OF 1934 [Fee Required]
   FOR THE YEAR ENDED DECEMBER 31, 1997

[  ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
   SECURITIES EXCHANGE ACT OF 1934 [No Fee Required]
                                
                  Commission File Number 0-9201
                                
                        BIO-RESPONSE, INC.
         (Name of small business issuer in its charter)
                                
Delaware                                     59-3453151
(state or other jurisdiction of incorporation or organization)
(IRS Employer identification No.)
                                
1612 N. Osceola Avenue, Clearwater, Florida    33755
(Address of principal executive offices)     (Zip Code)
                                
Issuer's telephone number:                 (813) 443 3434
                                
Securities Registered under Section 12(g) of the Exchange Act:
Common Stock, par value $.004 per share.

    Check whether the Issuer (1) filed all reports required to be
filed  by  Section  13 or 15(d) of the Exchange  Act  during  the
preceding  12 months (or for such shorter period that the  Issuer
was  required to file such reports), and (2) has been subject  to
such filing requirements for the past 90 days.
                                                  Yes [X]No [   ]

    Check if there is no disclosure of delinquent filers pursuant
to  Item  405  of Regulation S-B contained in this form,  and  no
disclosure  will be contained, to the best of Issuer's knowledge,
in  definitive  proxy or information statements  incorporated  by
reference  in  Part III of this Form 10-KSB or any  amendment  to
this Form 10-KSB.
                                                            [   ]

    The  issuer's revenues for its most recent fiscal  year  were
$0.

    The  aggregate market value of the 2,040,919 shares of Common
Stock,  $.0004 par value per share, held by non-affiliates  of  the
Issuer,  based on the closing sale price on December 27, 1997  of
$0.03  per share, was $61,228. However, since trading is sporadic
and   rare,  the  non-affiliates  holding  cannot  be  reasonably
assessed and the audit financials reflect zero value. The  number
of  shares of  the Common Stock, outstanding on December 31, 1997
was  9,176,554.  This outstanding number is subject to a  reverse
split  of  30.5885  to  1,approved by a Special  Meeting  of  the
Stockholders   held  on  March  10,  1997,   which   results   in
outstanding  shares of 300,000.  Further Ms. Fonner and  Capston,
in the same Special Meeting, were approved for a  compensation of
an   additional  200,000  shares  for  their  duties.  To   avoid
administrative  complexity associated with  effecting  a  reverse
split and requiring the stockholder to change certificates twice,
Management has elected to defer the issuance of stock to Capston,
Ms.  Fonner  or  her designees along with effecting  the  reverse
split until an acquisition is completed

    Check  whether the issuer has filed all documents and reports
required  to be filed by Sections 12, 13 or 15(d) of the Exchange
Act  after  the distribution of securities under a plan confirmed
by a court.
                                                Yes [   ]  No [X]

               DOCUMENTS INCORPORATED BY REFERENCE

   Not Applicable.
 PART I

Item 1. Description of Business

Corporate Background Information


     BIO-RESPONSE  conducted an initial public  offering  of  its
Common   Stock  in  September,  1979  pursuant  to  a  Form   S-2
Registration  Statement under the Securities  Act  of  1933  (the
"Securities Act"). In connection with an application to list  its
Common  Stock  on the NASDAQ system, the Company also  registered
its  Common  Stock  pursuant to Section 12(g) of  the  Securities
Exchange  Act of 1934 (the "Exchange Act"). The Company  remained
current  with  respect  to its reporting  obligations  under  the
Exchange Act until 1990.

     After  pursuing its business for several years, BIO-RESPONSE
filed a voluntary petition under Chapter 11 of the Bankruptcy Act
on September 14, 1989. This proceeding was filed in with the U.S.
Bankruptcy  Court  for the Northern District  of  California  and
designated as Case # 4-89-04159 N-3.   On September 15, 1995  the
Company's  case under Chapter 11 was closed by an  order  of  the
Court.  As a result of the Bankruptcy, the Company has no assets,
liabilities, management or ongoing operations and has not engaged
in any business activities for well over a half of a decade.

    During  the pendancy of the Bankruptcy, the Company  did  not
file  franchise  tax returns with and pay the required  franchise
taxes  to  the  State  of  Delaware. As a result,  the  Company's
corporate charter was revoked by order of the Secretary of  State
of  the  State  of Delaware on August 30, 1991.   Similarly,  the
Company  did not file with the SEC either (a) the regular reports
that   are   required  of  all  companies  that  have  securities
registered under the Exchange Act, or (b) a certification on Form
15  terminating  its registration under the Exchange  Act.  As  a
result, the Company remained a Registrant under the Exchange  Act
but  was  seriously delinquent in its SEC reporting  obligations.
According  to  Bloomberg, the last published  quotation  for  the
Company's Common Stock was posted by M. H. Meyerson & Co.,  Inc.,
one  of  the Company's market makers, on September  30, 1997.  At
this time, the published quote was $0.03 bid and $0.10 asked.

     In  1996,  acting  in its capacity as a Stockholder  of  the
Company,  and  without first receiving any consent,  approval  or
authorization  of any officer, director or other  Stockholder  of
the  Company, Capston effected a renewal, revival and restoration
of the Company's certificate of incorporation pursuant to Section
312  of the General Corporation Law of the State of Delaware.  In
general,  Section 312 provides that any corporation may  "procure
an  extension, restoration, renewal or revival of its certificate
of  incorporation,  together  with all  the  rights,  franchises,
privileges and immunities and subject to all of its duties, debts
and liabilities which had been secured or imposed by its original
certificate  of  incorporation"  upon  compliance  with   certain
procedural requirements.

    After reviewing the applicable files, Capston determined that
the  only debt of the Company that was "secured or imposed by its
original certificate" was the obligation of BIO-RESPONSE  to  pay
its   Delaware  taxes.  Therefore,  Capston  paid  all  past  due
franchise  taxes  on  behalf of the  Company  and  then  filed  a
Certificate of Renewal, Revival, Extension and Restoration of the
Company's  Certificate of Incorporation on behalf of the  Company
under  the authority granted by Section 312(h). The total out-of-
pocket  costs  paid  by Capston incurred in connection  with  the
restoration  of the Company's charter was $450.  This Certificate
was  filed in the office of the Secretary of  State of the  State
of  Delaware on December 26, 1996. and at the date of this report
the  Company  is lawfully incorporated, validly existing  and  in
good standing under the laws of the State of Delaware.


Operations


    The Company has no assets, liabilities, management or ongoing
operations  and  has not engaged in any business activities.   In
July  of  1997,  the Stockholders overwhelmingly  voted  for  the
adoption  and implementation of a Plan presented by  Capston  and
Ms.   Fonner,   (sole   director)   whereby   the   Company   was
restructured as a "public shell" for the purpose of  effecting  a
business  combination transaction with a suitable  privately-held
company that has both business history and operating assets.

    Capston and Ms. Fonner believes the Company offers owners  of
a  suitable privately-held company the opportunity to  acquire  a
controlling   ownership  interest  in   a   public   company   at
substantially  less  cost  than would otherwise  be  required  to
conduct  an  initial  public offering. Nevertheless,  neither  is
aware  of any empirical statistical data that would independently
confirm or quantify their beliefs concerning the perceived  value
of  a  merger  or  acquisition transaction for the  owners  of  a
suitable  privately-held  company. The  owners  of  any  existing
business  selected for a business combination  with  the  Company
will incur significant costs and expenses, including the costs of
preparing  the  required  business  combination  agreements   and
related  documents, the costs of preparing a  Current  Report  on
Form 8-K describing the business combination transaction and  the
costs  of preparing the documentation associated with any  future
reporting  under  the  Exchange Act and registrations  under  the
Securities Act.

    The  Plan  is  approved by the Stockholders. The  Company  is
fully reactivated and ready to be used as a corporate vehicle  to
seek,  investigate  and,  if the results  of  such  investigation
warrant, effect a business combination with a suitable privately-
held  company or other business opportunity presented  to  it  by
persons or firms that seek the perceived advantages of a publicly
held  corporation. The business operations proposed in  the  Plan
are  sometimes referred to as a "blind pool" because Stockholders
will  not  ordinarily have an opportunity to analyze the  various
business opportunities presented to the Company, or to approve or
disapprove the terms of any business combination transaction that
may  be  negotiated by Capston and Ms. Fonner on  behalf  of  the
Company.  Consequently, the Company's potential success  will  be
heavily  dependent on the efforts and abilities  of  Ms.  Fonner,
Capston  and  its  consultants  and  legal  advisors,  who   have
virtually unlimited discretion in searching for, negotiating  and
entering into a business combination transaction. Ms. Fonner  and
Capston  have had limited experience in the proposed business  of
the  Company. Although Ms. Fonner and Capston believes  that  the
Company  will  be  able  to  enter into  a  business  combination
transaction during 1998, there can be no assurance as to how much
time  will  elapse before a business combination is effected,  if
ever.   The  Company is not restrict its search to  any  specific
business, industry or geographical location, and the Company  may
participate  in  a  business venture of  virtually  any  kind  or
nature.

     Capston,   Ms.   Fonner,  legal  advisers  and   consultants
anticipate that the selection of a business opportunity  for  the
Company  will be complex and extremely risky. Because of  general
economic conditions, rapid technological advances being  made  in
some  industries,  and  shortages of available  capital,  Capston
believes that there are numerous privately-held companies seeking
the  perceived  benefits of a publicly traded  corporation.  Such
perceived  benefits may include facilitating  debt  financing  or
improving the terms on which additional equity or may be  sought,
providing liquidity for the principals of the business,  creating
a means for providing incentive stock options or similar benefits
to  key  employees, providing liquidity for all stockholders  and
other factors.

    Potential business opportunities may occur in many  different
industries  and at various stages of development,  all  of  which
will  make the task of comparative investigation and analysis  of
such  business  opportunities extremely  difficult  and  complex.
Capston,  Ms.  Fonner, legal advisers and consultants  anticipate
that the Company will be able to participate in only one business
venture.  This  lack of diversification should  be  considered  a
substantial risk inherent in the Plan because it will not  permit
the  Company to offset potential losses from one venture  against
gains  from another. Moreover, due to the Company's lack  of  any
meaningful financial, managerial or other resources, Capston. Ms.
Fonner,  legal advisers and consultants believe the Company  will
not  be  viewed  as a suitable business combination  partner  for
either  developing companies or established business that are  in
need of substantial additional capital.

Acquisition of Opportunities

      In   implementing   a   particular   business   combination
transaction,  the  Registrant may become a  party  to  a  merger,
consolidation,  reorganization,  joint  venture,   franchise   or
licensing  agreement with another corporation or entity.  It  may
also purchase stock or assets of an existing business. After  the
consummation of a business combination transaction, it is  likely
that  the present Stockholders of the Registrant will only own  a
small  minority interest in the combined companies. In  addition,
as  part of the terms of the acquisition transaction, all of  the
Registrant's officers and directors will ordinarily resign and be
replaced  by  new officers and directors without a  vote  of  the
Stockholders. Capston does not intend to obtain the  approval  of
the Stockholders prior to consummating any acquisition other than
a  statutory merger that requires a Stockholder vote. Capston and
its officers, directors and consultants do not intend to sell any
shares  held  by  them in connection with a business  acquisition
until  after the completion of  the acquisition occurs, and then,
only in an orderly manner.

    It  is  anticipated that any securities issued in a  business
combination transaction will be issued in reliance on  exemptions
from  registration under applicable Federal and state  securities
laws. In some circumstances, however, as a negotiated element  of
a business combination, the Registrant may agree to register such
securities  either at the time the transaction is consummated  or
at  some  specified time thereafter. The issuance of  substantial
additional  securities and their potential sale into any  trading
market  that  may develop may have a depressive  effect  on  such
market.  While  the actual terms of a transaction  to  which  the
Registrant may be a party cannot be predicted, it may be expected
that  the  parties  to  the  business transaction  will  find  it
desirable  to avoid the creation of a taxable event  and  thereby
structure   the   acquisition  in  a   so   called   "tax   free"
reorganization  under Sections 368(a)(1) or 351 of  the  Internal
Revenue Code of 1986, as amended (the "Code") In order to  obtain
tax  free treatment under the Code, it may be necessary  for  the
owners  of the acquired business to own 80% or more of the voting
stock of the surviving entity. In such event, the stockholders of
the  Registrant  would retain less than 20%  of  the  issued  and
outstanding shares of the combined companies, which could  result
in  significant dilution in the equity of such stockholders.  The
Registrant intends to structure any business combination in  such
manner  as to minimize Federal and state tax consequences to  the
Registrant and any target company.

    As  part  of  the  Registrant's  investigation  of  potential
business  opportunities, Capston and its officers, directors  and
consultants  will ordinarily meet personally with management  and
key  personnel, may visit and inspect material facilities, obtain
independent  analysis  or  verification  of  certain  information
provided,  check reference of management and key  personnel,  and
take  other reasonable investigative measures, to the  extent  of
the   Registrant's   limited  resources  and  Capston's   limited
expertise. The manner in which the Registrant participates in  an
opportunity  will  depend on the nature of the  opportunity,  the
respective needs and desires of the Registrant and other  parties
and  the relative negotiating strength of the Registrant and such
other management.

     With  respect  to  any  business  combination  negotiations,
Capston will ordinarily focus on the percentage of the Registrant
which  target company stockholders would acquire in exchange  for
their  ownership interest in the target company. Depending  upon,
among  other things, the target company's assets and liabilities,
the  Registrant's stockholders will in all likelihood only own  a
small minority interest in the combined companies upon completion
of the business combination transaction. Any business combination
effected  by the Registrant can be expected to have a significant
dilutive  effect  on  the  percentage  of  shares  held  by   the
Registrant's current Stockholders.

    Upon  completion of a business combination transaction, there
can  be  no  assurance  that  the combined  companies  will  have
sufficient   funds  to  undertake  any  significant  development,
marketing and manufacturing activities. Accordingly, the combined
companies  may  be  required to either seek  additional  debt  or
equity  financing  or  obtain  funding  from  third  parties,  in
exchange  for which the combined companies might be  required  to
issue  a substantial equity position. There is no assurance  that
the   combined  companies  will  be  able  to  obtain  additional
financing on terms acceptable to the combined companies.

    It is anticipated that the investigation of specific business
opportunities  and  the negotiation, drafting  and  execution  of
relevant  agreements, disclosure documents and other  instruments
will  require  substantial  management  time  and  attention  and
substantial  costs for accountants, attorneys and  others.  If  a
decision  is  made  not  to participate in  a  specific  business
opportunity the costs incurred in the related investigation would
not  be recoverable. Furthermore, even if an agreement is reached
for  the  participation in a specific business  opportunity,  the
failure to consummate that transaction may result in the loss  of
the Registrant of the related costs incurred.

Item 2. Description of Property

    As  a  result  of  its 1989 Bankruptcy, the  Company  has  no
assets, liabilities, or ongoing operations.  The Company  had  no
operations  during  the  year ended  December  31,  1997  and  no
material assets or liabilities as of December 31, 1997.

Item 3. Legal Proceedings

   Not Applicable

Item 4. Submission of matters to a vote of Security Holders

   Not Applicable

PART II

Item 5. Market for Registrant's Common Equity

    There has been no active trading in the Issuer's common stock
for  over five years. The Issuer does have six (6) market makers.
It  does not , however, have any active trading.  The highest bid
was  $.02 with the highest ask being $.07.  The Company's trading
symbol is BRSP and trades on the OTC.

Item 6. Management Discussion and Analysis of Financial Condition
and Results of Operations.

Results of Operations

    For  the  past  nine months, the Company  has  been  actively
seeking  an acquisition of assets, property or business that  may
benefit  the  Company and its stockholders. While  these  efforts
have not resulted in a suitable business combination transaction,
the  Company's experience during this period confirms that demand
for  well structured public shells is strong. Over the last eight
months,   the  Company  has  evaluated  a  number  of   potential
acquisition  candidates. In each case, however, the  Company  has
rejected  as  unsuitable because of several  reasons.   The  most
predominant  ones  were  capital  structure,  lack   of   audited
statements  and inadequate working capital.  In some  cases,  the
Company  was  rejected for unknown reasons. However, Capston
continues  to seek for a qualified candidate.

Financial Condition

    As  a  result  of  its 1989 Bankruptcy, the  Company  has  no
assets, liabilities, or ongoing operations and has not engaged in
any business activities since September 1989. The Company had  no
operations  during  the  year ended  December  31,  1997  and  no
material   assets  or  liabilities  as  of  December  31,   1997.
Stockholder  approved  the  Plan  whereby  the  Company  will  be
restructured as a "public shell" for the purpose of  effecting  a
business  combination transaction with a suitable  privately-held
company  that  has  both business history and  operating  assets,
although  there  can  be  no assurance that  management  will  be
successful in its efforts to negotiate such a transaction.

Plan of Operation.

    The Company has not engaged in any material operations or had
any  revenues from operations since its bankruptcy. The Company's
plan  of  operation for the next twelve months is to continue  to
seek  the  acquisition of assets, property or business  that  may
benefit the Company and its stockholders. Because the Company has
no  resources,  management anticipates that to achieve  any  such
acquisition, the Company will be required to issue shares of  its
common stock as the sole consideration for such acquisition.

    During the next twelve months, the Company's only foreseeable
cash  requirements will relate to maintaining the Company in good
standing or the payment of expenses associated with reviewing  or
investigating   any   potential  business  venture,   which   are
anticipated  to be advanced by Capston as loans to  the  Company.
Because the Company has not identified any such venture as of the
date  of this Registration Statement, it is impossible to predict
the  amount  of any such loans. However, any loans  from  Capston
will  be on terms no less favorable to the Company than would  be
available   from   a  commercial  lender  in  an   arm's   length
transaction. As of the date of this Annual Report on  Form  10-K,
the Company has not found any acquisition to date.

    Management  anticipates  that  Capston,  will  advance  minor
administrative expenses up to approximately $50,000. In the event
that  additional funding is required in order to keep the Company
in  good  standing and/or to review or investigate any  potential
merger or acquisition candidate, the Company may attempt to raise
such  funding through a private placement of its common stock  to
accredited investors.

    At the present time, management has no plans to offer or sell
any  securities  of the Company. However, at  such  time  as  the
Company  may decide to engage in such activities, management  may
use  any  legal means of conducting such offer or sale, including
registration  with the appropriate federal and  state  regulatory
agencies and any registration exemptions that may be available to
the Company under applicable federal and state laws.

    Because  the Company is not currently making any offering  of
its  securities, and does not anticipate making any such offering
in  the foreseeable future, management does not believe that Rule
419  promulgated by the Securities and Exchange Commission  under
the  Securities Act of 1933, as amended, concerning offerings  by
blank check companies, will have any effect on the Company or any
activities in which it may engage in the foreseeable future.

Item 7. Financial Statements.

   For the information called for by this Item, see the
Financial Statements attached.

Item 8. Changes in and Disagreements With Accountants on
Accounting and Financial Disclosure.

    The  Registrant's financial statements for  the  years  ended
December 31, 1989 were audited by the firm of TOUCHE ROSS &  Co.,
Certified  Public  Accountants. As a  result  of  the  bankruptcy
proceedings  discussed elsewhere herein, the Registrant  did  not
prepare financial statements for the years ended December 31,1990
through  December 31, 1996. In connection with  the  revival  and
restoration  of  the Company's certificate of incorporation,  the
firm  of  Want & Ender, Certified Public Accountants was retained
to  audit  the  Registrant's balance sheet  for  the  year  ended
December 31, 1996 and to serve as the Registrant's auditor in the
future.  During  the fiscal year ended 1990, and  the  subsequent
periods  preceding the appointment of Want & Ender,  CPAs,  there
were no known reportable disagreements between the Registrant and
the  firm of TOUCHE ROSS & Co., Certified Public Accountants,  on
any  matter  of  accounting principles  or  practices,  financial
statement disclosure, or auditing scope or procedure.

PART III

Item 9. Directors and Executive Officers of the Registrant

    Ms.  Sally Fonner, age 48, the president and sole stockholder
of   Capston,  performs  the  duties  of  President,   Secretary,
Treasurer and Sole Director of the Registrant. Ms. Fonner term of
office  is  anticipated  be  no more  than  two  years  or  until
permanent management can be located, whichever should occur first
in  time. Ms. Fonner's sole purpose is to seek out qualified  new
operations and management.  Ms. Fonner shall seek re-election  at
the annual meeting in 1998 if a business combination has not been
completed.

Item 10. Executive Compensation.

    Ms. Fonner is the sole officer and director of the Registrant
and  has received no monetary compensation for services performed
during  her  tenure.   Further, no future  monetary  compensation
agreement  between Ms. Fonner and the Registrant is contemplated.
Notwithstanding the foregoing, the Ms. Fonner was approved by the
stockholders  in  a  Special Meeting,  to  have  compensation  of
200,000  shares  of  stock,  not subject  to  the  reverse  split
approved   by  stockholders  in  the  same  meeting.   To   avoid
administrative  complexity associated with  effecting  a  reverse
split and requiring the stockholder to change certificates twice,
Management has elected to defer the issuance of stock to Capston,
Ms. Fonner or her designees until an acquisition is completed.

Item 11. Security Ownership of Certain Beneficial Owners and
Management

    The  following  table presents certain information  regarding
the  beneficial ownership of the Company's equity  securities  at
February 28, 1997 by (i) each person known by the Company to  own
beneficially  more than 5% of the outstanding  shares  of  Common
Stock,  (ii)  each of the Company's directors and  officers,  and
(iii) all directors and officers as a group.
                         Number of SharesPercent of
     Name            Beneficially Owned (1) Class
      Eli S. Jacobs          2,975,218    32.4%
      375 Park Avenue
      New York, New York
      10022

     Executive Life
     Insurance Co           3,157,891     12.5%
     11444 West Olympic Boulevard
     Los Angeles, California
     90064

    Elliott Associates,
    L.P.                    1,000,526        9.8%
    110 E. 59th Street
    New York, New York
    10022

    Capston Network Company     2,000      .0002%
    1612 N. Osceola Avenue
    Clearwater, Florida 34615
   
    All directors and officers
    as a group.                 2,000         .0002%

The above information, with the exception of Capston Network
Company, is taken from the last filed 10-K dated June 30, 1989.
Capston has no information which would lead them to change the
above data.

(1)Unless  otherwise  indicated, each person or  group  has  sole
   voting  and  investment  power  with  respect  to  all  listed
   shares.

    The  Company knows of no arrangements that will result  in  a
change in control at a date after this Annual Report on Form  10-
KSB,  however, the Issuer's proposed Proxy Statement will provide
for   significant  stock  compensation  to  certain   individuals
selected  by Capston in the event that the plan of reorganization
described therein is approved by the Stockholders.

Item 12. Certain Relationships and Related Transactions

   No officer, director or family member of an officer or
director has engaged in any material transaction with the issuer
since the beginning of the Issuer's most recent fiscal year..

Item 13. Exhibits and Reports on Form 8-K.

Financial statements filed with this report:

   Independent Auditor's report for December 31, 1996 and
   December 31, 1997.
    Balance Sheet of December 31, 1996 and December 31, 1997.
    Statements of Income for December 31, 1996 and December 31,
    1997.
    Shareholders Equity for December 31, 1996 and December 31,
    1997.


 SIGNATURES

  Pursuant  to  the requirements of Section 13 or  15(d)  of  the
Exchange Act of 1934, the Registrant has duly caused this  report
to  be  signed  on its behalf by the undersigned, thereunto  duly
authorized.

Bio-Response, Inc.
Date:April 15, 1998    By_____/s/_______________
                       Sally Fonner,
                       Director
                       President
                       and Chief Financial Officer

  Pursuant to the requirements of the Securities Exchange Act  of
1934 this report has been signed below by the following person on
behalf  of the Registrant and in the capacities and on  the  date
indicated.

Date : _4/15/98    By______/s/_______________
                      Sally Fonner,
                      Director
                      President
                      and Chief Financial Officer


































WANT &: ENDER, CPA, P.C.
CERTIFIED PUBLIC ACCOUNTANTS        37 East 28th Street, 8th Floor
                                   New York, NY 10016
MARTIN UNDER, CPA                  Telephone (212) 684-2414
STANLEY Z. WANT, CPA, CFP                           Fax (212) 684-5433

                  Independent Auditor's Report

To the Shareholders and Board of Directors
BIO-RESPONSE, INC.

We have audited the accompanying consolidated balance sheet of
BIO-RESPONSE, INC. (A Dormant State Company) at December 31, 1997
and December 31, 1996 and the related consolidated statements of
operations, shareholders' equity/(deficit), and cash flows for
the years then ended. These financial statements are the
responsibility of the Company's management. Our responsibility is
to express an opinion on these financial statements based on our
audit.

We have conducted our audit in accordance with generally accepted
auditing standards. These standards require that we plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An
audit also includes examining on a test basis, evidence
supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as
well as evaluating the overall financial statement presentation.
We believe our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to
above present fairly, in all material respects, the financial
position of BIO-RESPONSE, INC. (A Dormant State Company) at
December 31, 1997 and the results of its operations and its cash
flows for the years then ended in conformity with generally
accepted accounting principles.

/s/

Martin Ender
Want & Ender CPA, P.C.
Certified Public Accountants

New York, NY
March 17, 1998
                       BIO-RESPONSE, INC.
                   ( A Dormant State Company)
                   Consolidated Balance Sheets
                   December 31, 1997 and 1996

                                              1997                1996

ASSETS

Organization Cost                             0                     0

                                             _______             _______

Total Assets                                    0                    0
                                             _______             _______




LIABILITIES AND STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY
Common Stock, par value $.004 per share;
20,000,000 shares authorized;
9,176,554 shares issued and outstanding          0            0
Additional Paid in Capital                      41,945        350
Net Profit/(Loss)                              (41,945)       (350)
                                  
Total Stockholders' Equity                      0               0
                                  



Total Liabilities and
Stockholders' Equity                             0              0
                                   
                                   
         See accompanying notes to financial statements


                       BIO-RESPONSE, INC.
                    (A Dormant State Company)
              Consolidated Statements of Operations
          For the Year Ended December 31, 1997 and 1996
                                
                                

                                 1997             1996

Revenues                          $               0 $                0


Expenses
Administrative Expenses          (41,945)           0
Filing Fees                                       (350)



Net Income/Loss for the year$(41,945)            $ (350)





         See accompanying notes to financial statements

!

                       BIO-RESPONSE, INC.
                    (A Dormant State Company)
       Consolidated Statement of Changes in Shareholders'
                        Equity/(Deficit)
         For the years ended December 31, 1997 and 1996

                                   1997        1996



Common Stock
(9,176,554 SHARES ISSUED & OUTSTANDING)      $     0 $                  0
Additional Paid in Capital                    42,255                  350

Balance January                                 (350)                   0

Net Income/(Loss) for the year                (41,945)               (350)

Balance December 31                                  0                  0




    See accompanying notes to financial statements
                                                                 


                       BIO-RESPONSE, INC.
                     Statement of Cash Flows
             For the Period Ended December 31, 1997

                                Current Year                Prior Year
                                  12-31-97                  12-31-96
                                             
                           Cash Flows from Operating Activities
                          
Net Income                        $(41,945)           $          (350)
Net Cash Provided (Used)
By Operating Activities           $ 41,945                        350


Cash Flows from Financing
Activities                               0                       0
Proceeds from Capston-Paid in
Capital                              41,945                     350

Net Cash Provided (Used)
By Financing Activities                    0                     0

Net Increase (Decrease) in Cash            0                     0
Cash at Beginning of Period                0                     0
Cash at End of Period                  S   0                S    0



                       BIO-RESPONSE, INC.
                    (A Dormant State Company)

                        December 31, 1997


Note 1. HISTORY OF THE COMPANY

BIO-RESPONSE,  Inc., (A Dormant State Company), was  incorporated
on  1972,  under the laws of the State of Delaware.  The  Company
conducted  an  initial public offering of  its  Common  Stock  in
January,  1979 and in connection with an application to list  its
Common  Stock  on the NASDAQ system, the Company also  registered
its  Common  Stock  pursuant to Section 12(g) of  the  Securities
Exchange Act of 1934.

On   September 14, 1989, the  Company filed a voluntary  petition
under Chapter 11 of the Bankruptcy Act (Case  No. 4-89-04159 N-3)
in  the  U.S.  Bankruptcy  Court for  the  Northern  District  of
California.   On  September 15, 1995, the  Company's  case  under
Chapter  11  was closed under court order.  As a  result  of  the
bankruptcy case, all assets of the Company were overseen  by  the
Trustee  in  Bankruptcy.  The assets were sold  and  the  Company
ceased  all  operations.  The Trustee in Bankruptcy  effected  an
orderly liquidation of corporate assets and used the proceeds  to
repay  the  Company's  creditors.   On  September  15,  1995  the
Company's  case under Chapter 11 was closed by an  order  of  the
Court  and the Trustee in Bankruptcy was discharged.  As a result
of  the  Bankruptcy,  the  Company has  no  assets,  liabilities,
management  or  ongoing operations and has  not  engaged  in  any
business activities  for well over a half of a decade.

Note 2. RESTORATION OF CORPORATE STATUS

On  June  10, 1996, acting in its capacity as the holder of  2000
shares  (0.0002%)   of the Company's common  stock,  and  without
first  receiving  the consent, approval or authorization  of  any
other person associated with the Company, Capston Network Company
effected  a  renewal, revival and restoration  of  the  Company's
certificate  of  incorporation pursuant to  Section  312  of  the
General Corporation Law of Delaware.  Thereafter, Capston filed a
10-K  for  the years ending December 31, 1990-1996, and  a  Proxy
Statement seeking approval and ratification of its actions, along
with  authorization  to  seek  a  suitable  business  combination
transaction.  This proxy statement was ultimately distributed  to
the   Company's  stockholders  and  the  proposals  therein  were
approved by the holders of a majority of the Company's issued and
outstanding shares.

Under  the  terms  of the original Proxy Statement,  Capston  was
authorized to seek a suitable business combination transaction on
behalf  of  the Company and to submit the terms of  any  proposed
business  combination  transaction to the Company's  stockholders
for their approval.  Capston did not receive and was not entitled
to receive any equity interest in the Company as a result of it's
actions  prior  to  the  date of the Proxy Statement.   Moreover,
Capston  was  not  entitled  to reimbursement  for  any  expenses
incurred  by  it  on behalf of the Company except to  the  extent
that the terms of a business combination transaction provided for
the reimbursement of such expenses. However, because Sally Fonner
is  both the President of BIO-RESPONSE and  Capston, prior  Staff
Accounting  Bulletins require under generally accepted accounting
principles   the   treatment  of  debiting  the   expenses   with
corresponding  credit  to paid-in capital.   Future  expenses  of
Capston  or others  will be treated this way. These expenses  are
actual  cash expenditures and do not reflect any costs associated
with the operation of Capston nor any personnel time or cost.

Note 3. FUTURE EXPENSES

Capston  will continue to extend administrative expenses to  keep
BIO-RESPONSE current with its reporting requirements, keeping the
Corporation in good standing, any required proxy solicitation  or
acquisition efforts.  These amounts should not exceed $50,000  in
out-of-pockets costs.  In addition, as approved, and as a  result
of  a  suitable acquisition, additional fees paid for by issuance
of  equity position  would be for: (i) Capston of 200,000 shares,
(ii)up to 4,500,000 shares for  an acquisition(s) and (iii) up to
5% of the acquisition for a finder's fee .


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission